AbbVie Inc. (ABBV)

Statement of Comprehensive Income

Low level of difficulty

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

AbbVie Inc., consolidated statement of comprehensive income

US$ in millions

12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Net earnings	5,687	5,309	5,953	5,144	1,774
Foreign currency translation adjustments, net of tax	(391)	996	(165)	(667)	(1,073)
Net investment hedging activities, net of tax	138	(343)	140	—	—
Pension and post-employment benefits, net of tax	197	(406)	(135)	230	(781)
Marketable security activities, net of tax	(10)	(46)	(1)	44	1
Cash flow hedging activities, net of tax	313	(342)	136	(137)	264
Other comprehensive income (loss)	247	(141)	(25)	(530)	(1,589)
Comprehensive income	5,934	5,168	5,928	4,614	185

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20).

Comprehensive income item	Description	The company
Net earnings	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	AbbVie Inc.’s net earnings declined from 2016 to 2017 but then increased from 2017 to 2018 not reaching 2016 level.
Comprehensive income	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.	AbbVie Inc.’s comprehensive income declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.